CJC/IPA

CJC-1295 (No DAC) - 10mg + Ipamorelin - 10mg

CJC-1295 activates GHRH receptors via albumin-binding DAC technology for sustained elevation. Ipamorelin selectively activates ghrelin receptors (GHSR1a) without affecting ACTH/cortisol, preserving natural pulsatile GH patterns.

Benefits

• Sustained GH elevation (6-8 days from CJC-1295)
• Selective pulsatile release without cortisol suppression
• Complementary dual-pathway optimization
• Preservation of natural GH rhythm
• Enhanced muscle protein synthesis and recovery